Cargando…

Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models

The global burden of diabetes has drastically increased over the past decades and in 2017 approximately 4 million deaths were caused by diabetes and cardiovascular complications. Diabetic cardiomyopathy is a common complication of diabetes with early manifestations of diastolic dysfunction and left...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granéli, Cecilia, Hicks, Ryan, Brolén, Gabriella, Synnergren, Jane, Sartipy, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513824/ https://www.ncbi.nlm.nih.gov/pubmed/30343468 http://dx.doi.org/10.1007/s12015-018-9858-1

Ejemplares similares

Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
por: Holmgren, Gustav, et al.
Publicado: (2015)

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
por: Brodehl, Andreas, et al.
Publicado: (2019)

Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells
por: Pavez-Giani, Mario G., et al.
Publicado: (2022)

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy
por: Knight, Walter E., et al.
Publicado: (2021)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
por: Li, Jiangtao, et al.
Publicado: (2022)

A data analysis framework for biomedical big data: Application on mesoderm differentiation of human pluripotent stem cells
por: Ulfenborg, Benjamin, et al.
Publicado: (2017)

Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models
por: Lundin, Anders, et al.
Publicado: (2018)

Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
por: Eisen, Binyamin, et al.
Publicado: (2023)

Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytes
por: Higo, Shuichiro
Publicado: (2023)

Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes
por: De Bortoli, Marzia, et al.
Publicado: (2023)

Cardiac hypertrophy in a dish: a human stem cell based model
por: Johansson, Markus, et al.
Publicado: (2020)

Recent Advances in Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Promoted by Mechanical Stretch
por: Gu, Xingwang, et al.
Publicado: (2021)

Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy
por: Johansson, Markus, et al.
Publicado: (2022)

Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
por: Yang, Hao, et al.
Publicado: (2023)

The recent advances in the mathematical modelling of human pluripotent stem cells
por: Wadkin, L. E., et al.
Publicado: (2020)

Human Pluripotent Stem Cell-Derived Hepatocytes Show Higher Transcriptional Correlation with Adult Liver Tissue than with Fetal Liver Tissue
por: Ghosheh, Nidal, et al.
Publicado: (2020)

Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes
por: Kumar, Satish, et al.
Publicado: (2021)

Human-Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for TNNT2 Δ160E-Induced Cardiomyopathy
por: Kondo, Takumi, et al.
Publicado: (2022)

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes
por: Zhang, Yiyu, et al.
Publicado: (2021)

Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models
por: Chua, Christianne J., et al.
Publicado: (2023)

Highly Synchronized Expression of Lineage-Specific Genes during In Vitro Hepatic Differentiation of Human Pluripotent Stem Cell Lines
por: Ghosheh, Nidal, et al.
Publicado: (2016)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
por: Eschenhagen, Thomas, et al.
Publicado: (2018)

Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy
por: Lee, Yee-Ki, et al.
Publicado: (2016)

Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells
por: Wong, Maggie M. K., et al.
Publicado: (2017)

Pluripotent stem cells for cardiac regeneration: Overview of recent advances & emerging trends
por: Pawani, Harsha, et al.
Publicado: (2013)

Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood–brain barrier model
por: Delsing, Louise, et al.
Publicado: (2019)

Characterization of Human Induced Pluripotent Stem Cell-Derived Hepatocytes with Mature Features and Potential for Modeling Metabolic Diseases
por: Holmgren, Gustav, et al.
Publicado: (2020)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
por: Maillet, Agnes, et al.
Publicado: (2016)

Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Shemer, Yuval, et al.
Publicado: (2021)

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells
por: Khedro, Tarek, et al.
Publicado: (2022)

Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal Models
por: Purnama, Ujang, et al.
Publicado: (2022)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
por: Prajapati, Chandra, et al.
Publicado: (2018)

Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
por: Sharma, Arun, et al.
Publicado: (2013)

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
por: Hulot, Jean-Sébastien, et al.
Publicado: (2014)

Modelling cadmium‐induced cardiotoxicity using human pluripotent stem cell‐derived cardiomyocytes
por: Shen, Jiaxi, et al.
Publicado: (2018)

Perspective on human pluripotent stem cell‐derived cardiomyocytes in heart disease modeling and repair
por: Li, Qiang, et al.
Publicado: (2020)

A dual cardiomyocyte reporter model derived from human pluripotent stem cells
por: Jiang, Yuqian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uu0m5anqntm6rdahjmq4plb2hm